Additional analysis and Buy / Sell / Hold recommendations have been made by DEUTSCHE BK SEC, BAS - ML and MORGAN STANLEY. If you are a client or partner of one of these firms, you can gain access by registering for access or logging in
Even though the Neutral firms are pleased with Cubist’s favorable settlement with Teva, they are concerned about the overdependence of Cubist on Cubicin. They believe that Cubist has to launch new products to sustain growth.
Last edited Fri Jun 24, 2011 04:44 AM by gourabdas (Individual Investor)
Created by: WikiMigrationBot.
Last Modification: Thursday 03 of June, 2010 06:30:11 CDT by WikiMigrationBot.
